Cargando…

Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development

BACKGROUND: Testicular germ cell cancer (TGCC), being the most frequent malignancy in young Caucasian males, is initiated from an embryonic germ cell. This study determines intratumour heterogeneity to unravel tumour progression from initiation until metastasis. METHODS: In total, 42 purified sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorssers, Lambert C. J., Gillis, Ad J. M., Stoop, Hans, van Marion, Ronald, Nieboer, Marleen M., van Riet, Job, van de Werken, Harmen J. G., Oosterhuis, J. Wolter, de Ridder, Jeroen, Looijenga, Leendert H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461884/
https://www.ncbi.nlm.nih.gov/pubmed/30739914
http://dx.doi.org/10.1038/s41416-019-0381-1
_version_ 1783410550736158720
author Dorssers, Lambert C. J.
Gillis, Ad J. M.
Stoop, Hans
van Marion, Ronald
Nieboer, Marleen M.
van Riet, Job
van de Werken, Harmen J. G.
Oosterhuis, J. Wolter
de Ridder, Jeroen
Looijenga, Leendert H. J.
author_facet Dorssers, Lambert C. J.
Gillis, Ad J. M.
Stoop, Hans
van Marion, Ronald
Nieboer, Marleen M.
van Riet, Job
van de Werken, Harmen J. G.
Oosterhuis, J. Wolter
de Ridder, Jeroen
Looijenga, Leendert H. J.
author_sort Dorssers, Lambert C. J.
collection PubMed
description BACKGROUND: Testicular germ cell cancer (TGCC), being the most frequent malignancy in young Caucasian males, is initiated from an embryonic germ cell. This study determines intratumour heterogeneity to unravel tumour progression from initiation until metastasis. METHODS: In total, 42 purified samples of four treatment-resistant nonseminomatous (NS) TGCC were investigated, including the precursor germ cell neoplasia in situ (GCNIS) and metastatic specimens, using whole-genome and targeted sequencing. Their evolution was reconstructed. RESULTS: Intratumour molecular heterogeneity did not correspond to the supposed primary tumour histological evolution. Metastases after systemic treatment could be derived from cancer stem cells not identified in the primary cancer. GCNIS mostly lacked the molecular marks of the primary NS and comprised dominant clones that failed to progress. A BRCA-like mutational signature was observed without evidence for direct involvement of BRCA1 and BRCA2 genes. CONCLUSIONS: Our data strongly support the hypothesis that NS is initiated by whole-genome duplication, followed by chromosome copy number alterations in the cancer stem cell population, and accumulation of low numbers of somatic mutations, even in therapy-resistant cases. These observations of heterogeneity at all stages of tumourigenesis should be considered when treating patients with GCNIS-only disease, or with clinically overt NS.
format Online
Article
Text
id pubmed-6461884
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64618842019-09-11 Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development Dorssers, Lambert C. J. Gillis, Ad J. M. Stoop, Hans van Marion, Ronald Nieboer, Marleen M. van Riet, Job van de Werken, Harmen J. G. Oosterhuis, J. Wolter de Ridder, Jeroen Looijenga, Leendert H. J. Br J Cancer Article BACKGROUND: Testicular germ cell cancer (TGCC), being the most frequent malignancy in young Caucasian males, is initiated from an embryonic germ cell. This study determines intratumour heterogeneity to unravel tumour progression from initiation until metastasis. METHODS: In total, 42 purified samples of four treatment-resistant nonseminomatous (NS) TGCC were investigated, including the precursor germ cell neoplasia in situ (GCNIS) and metastatic specimens, using whole-genome and targeted sequencing. Their evolution was reconstructed. RESULTS: Intratumour molecular heterogeneity did not correspond to the supposed primary tumour histological evolution. Metastases after systemic treatment could be derived from cancer stem cells not identified in the primary cancer. GCNIS mostly lacked the molecular marks of the primary NS and comprised dominant clones that failed to progress. A BRCA-like mutational signature was observed without evidence for direct involvement of BRCA1 and BRCA2 genes. CONCLUSIONS: Our data strongly support the hypothesis that NS is initiated by whole-genome duplication, followed by chromosome copy number alterations in the cancer stem cell population, and accumulation of low numbers of somatic mutations, even in therapy-resistant cases. These observations of heterogeneity at all stages of tumourigenesis should be considered when treating patients with GCNIS-only disease, or with clinically overt NS. Nature Publishing Group UK 2019-02-11 2019-02-19 /pmc/articles/PMC6461884/ /pubmed/30739914 http://dx.doi.org/10.1038/s41416-019-0381-1 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Dorssers, Lambert C. J.
Gillis, Ad J. M.
Stoop, Hans
van Marion, Ronald
Nieboer, Marleen M.
van Riet, Job
van de Werken, Harmen J. G.
Oosterhuis, J. Wolter
de Ridder, Jeroen
Looijenga, Leendert H. J.
Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
title Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
title_full Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
title_fullStr Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
title_full_unstemmed Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
title_short Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
title_sort molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461884/
https://www.ncbi.nlm.nih.gov/pubmed/30739914
http://dx.doi.org/10.1038/s41416-019-0381-1
work_keys_str_mv AT dorsserslambertcj molecularheterogeneityandearlymetastaticcloneselectionintesticulargermcellcancerdevelopment
AT gillisadjm molecularheterogeneityandearlymetastaticcloneselectionintesticulargermcellcancerdevelopment
AT stoophans molecularheterogeneityandearlymetastaticcloneselectionintesticulargermcellcancerdevelopment
AT vanmarionronald molecularheterogeneityandearlymetastaticcloneselectionintesticulargermcellcancerdevelopment
AT nieboermarleenm molecularheterogeneityandearlymetastaticcloneselectionintesticulargermcellcancerdevelopment
AT vanrietjob molecularheterogeneityandearlymetastaticcloneselectionintesticulargermcellcancerdevelopment
AT vandewerkenharmenjg molecularheterogeneityandearlymetastaticcloneselectionintesticulargermcellcancerdevelopment
AT oosterhuisjwolter molecularheterogeneityandearlymetastaticcloneselectionintesticulargermcellcancerdevelopment
AT deridderjeroen molecularheterogeneityandearlymetastaticcloneselectionintesticulargermcellcancerdevelopment
AT looijengaleenderthj molecularheterogeneityandearlymetastaticcloneselectionintesticulargermcellcancerdevelopment